Brazilian Pharmaceuticals & Biotech Potentially Undervalued Companies

Johnson & Johnson

Market Cap: R$366.8b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Blau Farmacêutica

Market Cap: R$2.5b

A pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.

Novo Nordisk

Market Cap: R$2.0t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

GSK

Market Cap: R$58.7b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Regeneron Pharmaceuticals

Market Cap: R$62.5b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Amgen

Market Cap: R$149.7b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Teva Pharmaceutical Industries

Market Cap: R$20.8b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Bristol-Myers Squibb

Market Cap: R$95.6b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Merck

Market Cap: R$191.3b

Operates as a healthcare company worldwide.

Novartis

Market Cap: R$181.7b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

BeiGene

Market Cap: R$28.2b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

United Therapeutics

Market Cap: R$13.9b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Perrigo

Market Cap: R$3.7b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Biogen

Market Cap: R$18.7b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Hypera

Market Cap: R$15.9b

Operates as a pharmaceutical company in Brazil.

Exelixis

Market Cap: R$11.6b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Exact Sciences

Market Cap: R$11.0b

Provides cancer screening and diagnostic test products in the United States and internationally.

Gilead Sciences

Market Cap: R$135.7b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Pfizer

Market Cap: R$131.8b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Incyte

Market Cap: R$12.6b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Jazz Pharmaceuticals

Market Cap: R$6.6b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

CRISPR Therapeutics

Market Cap: R$3.2b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Azenta

Market Cap: R$1.2b

Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

BioMarin Pharmaceutical

Market Cap: R$11.1b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

argenx

Market Cap: R$31.5b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

IQVIA Holdings

Market Cap: R$24.0b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Thermo Fisher Scientific

Market Cap: R$151.8b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Ultragenyx Pharmaceutical

Market Cap: R$3.3b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.